臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

Jump to a point in the index:
Or type in a year:

Show Most Recent First

Ordering With Oldest First

Showing items 2264356-2264380 of 2310863 (92435 Page(s) Totally)
<< < 90570 90571 90572 90573 90574 90575 90576 90577 90578 90579 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-06-10T06:11:07Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shao Y.-Y.; Lu L.-C.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:07Z	Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer	Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏	2022-06-10T06:11:08Z	Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: An East Asian population-based study	ZHONG-ZHE LIN; Shau W.-Y.; Shao Y.-Y.; Yang Y.-Y.; Kuo R.N.-C.; Yang J.C.-H.; Laie M.-S.
臺大學術典藏	2022-06-10T06:11:08Z	The impact of diabetes mellitus on prognosis of early breast cancer in Asia	Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2022-06-10T06:11:08Z	Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma	Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; ZHONG-ZHE LIN; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2022-06-10T06:11:08Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	ZHONG-ZHE LIN; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.
臺大學術典藏	2022-06-10T06:11:09Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:09Z	Survival of patients with small cell lung carcinoma in Taiwan	Kuo Y.-H.; ZHONG-ZHE LIN; Yang Y.-Y.; Shao Y.-Y.; Shau W.-Y.; Kuo R.N.C.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏	2022-06-10T06:11:10Z	A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor	Yang S.-H.; Lin C.-C.; ZHONG-ZHE LIN; Tseng Y.-L.; Hong R.-L.
臺大學術典藏	2022-06-10T06:11:10Z	High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy	Shao Y.-Y.; ZHONG-ZHE LIN; Chen T.-J.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:10Z	Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma	Shao Y.U.-Y.; Chen P.-J.; ZHONG-ZHE LIN; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:11Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:11Z	Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC	ZHONG-ZHE LIN; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Tsao H.-W.; Lai P.; Lee P.; Cheng A.-L.; Hsu H.-C.
臺大學術典藏	2022-06-10T06:11:12Z	Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma	Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; ZHONG-ZHE LIN; Chao T.-Y.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:12Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T.
臺大學術典藏	2022-06-10T06:11:12Z	Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma	Shao Y.; Huang C.; Liang P.; ZHONG-ZHE LIN
臺大學術典藏	2022-06-10T06:11:13Z	A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting	Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y.
臺大學術典藏	2022-06-10T06:11:13Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	Yang S.-H.; ZHONG-ZHE LIN; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:13Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Shen Y.-C.; ZHONG-ZHE LIN; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:13Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Cheng A.-L.; Yang P.-C.
臺大學術典藏	2022-06-10T06:11:14Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	ZHONG-ZHE LIN; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:14Z	Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment	Shao Y.-Y.; ZHONG-ZHE LIN; Liang P.-C.; Tien Y.-W.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:14Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; ZHONG-ZHE LIN; Chang M.-C.; Hsu C.; Cheng A.-L.
臺大學術典藏	2022-06-10T06:11:15Z	High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy	Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y.
臺大學術典藏	2022-06-10T06:11:15Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.

Showing items 2264356-2264380 of 2310863 (92435 Page(s) Totally)
<< < 90570 90571 90572 90573 90574 90575 90576 90577 90578 90579 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2826208
	Visitors : 31903327 Online Users : 1472 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library